Evidence map›Paper›PMID 35330391›Full record

ArticleJournal of personalized medicine2022

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome.

Carles Perpiñan, Laia Bertran, Ximena Terra, Carmen Aguilar, Jessica Binetti, Miguel Lopez-Dupla, Anna Rull, Laia Reverté, Elena Yeregui, Frederic Gómez-Bertomeu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The Important Role of Interleukin-2 in COVID-19.Journal of immunology research · 2023
    Review
  10. Article
  11. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.Biochimica et biophysica acta. Molecular basis of disease · 2022
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Carles PerpiñanCentre d'Atenció Primària (CAP) Sant Pere, Institut Català de la Salud (ICS), 43202 Reus, Spain.
Laia BertranGEMMAIR Research Group, Department of Medicine and Surgery, Faculty of Medicine, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.ORCID 0000-0001-9052-1368
Ximena TerraMoBioFood Research Group, Department of Biochemistry and Biotechnology, Faculty of Chemistry, URV, IISPV, 43007 Tarragona, Spain.ORCID 0000-0003-1043-5844
Carmen AguilarGEMMAIR Research Group, Department of Medicine and Surgery, Faculty of Medicine, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.
Jessica BinettiGEMMAIR Research Group, Department of Medicine and Surgery, Faculty of Medicine, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.
Miguel Lopez-DuplaInternal Medicine Unit, Hospital Universitari de Tarragona Joan XXIII (HJ23), ICS, 43007 Tarragona, Spain.ORCID 0000-0002-9141-2523
Anna RullINIM Research Group, Department of Medicine and Surgery, Faculty of Medicine, URV, IISPV, 43007 Tarragona, Spain.ORCID 0000-0002-8907-7754
Laia RevertéINIM Research Group, Department of Medicine and Surgery, Faculty of Medicine, URV, IISPV, 43007 Tarragona, Spain.ORCID 0000-0003-4690-2387
Elena YereguiINIM Research Group, Department of Medicine and Surgery, Faculty of Medicine, URV, IISPV, 43007 Tarragona, Spain.
Frederic Gómez-BertomeuMicrobiology Unit, Laboratori Clínic Camp de Tarragona, HJ23, ICS, 43007 Tarragona, Spain.ORCID 0000-0002-8039-2889
Joaquim PeraireInternal Medicine Unit, Hospital Universitari de Tarragona Joan XXIII (HJ23), ICS, 43007 Tarragona, Spain.ORCID 0000-0001-7808-5479
Teresa AuguetGEMMAIR Research Group, Department of Medicine and Surgery, Faculty of Medicine, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.ORCID 0000-0003-0396-6428
On Behalf Of Covid-Study Group
Institut de Recerca Biomèdica Catalunya Sud · ESHospital Universitari Joan XXIII de Tarragona · ESInstitut Català de la Salut · ES

Funding

Direcció General de Recerca i Innovació en Salut PoC-6-17
6 · The paper itself

Abstract

The cytokine signature present in COVID-19 could provide information on the pathogenic mechanisms of the disease and could identify possible prognostic biomarkers and possible therapeutic targets. In this longitudinal work, we studied the clinical and biochemical parameters and circulating cytokine levels of 146 patients at the time of admission for COVID-19 and 4-6 weeks later. The main objective of this study was to determine whether basal cytokines could be early prognostic biomarkers of COVID-19, and also to analyze the impact of comorbidities, such as obesity or metabolic syndrome (MS), in the cytokine profile. The levels of most inflammatory cytokines were elevated on admission in relation to the level that was reached 4-6 weeks later, except for IL-1β, which was lower on admission; these levels were irrespective of the presence of obesity or MS since the cytokine storm masks these inflammatory processes. Among the cytokines analyzed, those that correlated with a worse prognosis of COVID-19 were resistin, IL-6, IL-8, IL-15, MCP-1 and TNF-α. Specifically, resistin and IL-15 are the best early predictors of requiring invasive ventilation. Therefore, resistin and IL-15 should be included in the personalized treatment decision algorithm of patients with COVID-19.

Indexed as

COVID-19cytokinesmetabolic syndromeobesitypredictionSARS-CoV-2

Identifiers

PMID35330391
PMCPMC8955294
OpenAlexW4214820236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.